Should You Avoid BioDelivery Sciences International, Inc. (BDSI)? – ArQule, Inc. (ARQL), Amicus Therapeutics, Inc. (FOLD)

Page 1 of 2

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) investors should pay attention to a decrease in support from the world’s most elite money managers in recent months.

BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

In today’s marketplace, there are tons of metrics shareholders can use to watch the equity markets. Some of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite hedge fund managers can outperform the market by a solid amount (see just how much).

Just as key, optimistic insider trading sentiment is another way to break down the stock market universe. Obviously, there are a variety of motivations for a bullish insider to sell shares of his or her company, but just one, very obvious reason why they would buy. Several empirical studies have demonstrated the valuable potential of this tactic if “monkeys” understand where to look (learn more here).

Consequently, it’s important to take a peek at the recent action surrounding BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

What does the smart money think about BioDelivery Sciences International, Inc. (NASDAQ:BDSI)?

Heading into 2013, a total of 9 of the hedge funds we track were long in this stock, a change of -10% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of notable hedge fund managers who were boosting their holdings meaningfully.

According to our comprehensive database, Adage Capital Management, managed by Phill Gross and Robert Atchinson, holds the biggest position in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Adage Capital Management has a $10 million position in the stock, comprising 0% of its 13F portfolio. Sitting at the No. 2 spot is Julian Baker and Felix Baker of Baker Bros. Advisors, with a $9 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining hedge funds that are bullish include Kevin Kotler’s Broadfin Capital, James E. Flynn’s Deerfield Management and Gregory Fraser, Rudolph Kluiber, and Timothy Kroch’s GRT Capital Partners.

Since BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has witnessed falling interest from hedge fund managers, it’s safe to say that there exists a select few money managers that slashed their positions entirely last quarter. Interestingly, Peter Algert and Kevin Coldiron’s Algert Coldiron Investors sold off the biggest stake of the “upper crust” of funds we watch, totaling close to $0 million in stock.. Mike Vranos’s fund, Ellington, also cut its stock, about $0 million worth. These transactions are interesting, as total hedge fund interest was cut by 1 funds last quarter.

How have insiders been trading BioDelivery Sciences International, Inc. (NASDAQ:BDSI)?

Insider buying is particularly usable when the company in question has experienced transactions within the past half-year. Over the latest six-month time frame, BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has experienced 2 unique insiders buying, and 2 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to BioDelivery Sciences International, Inc. (NASDAQ:BDSI). These stocks are Cytokinetics, Inc. (NASDAQ:CYTK), ArQule, Inc. (NASDAQ:ARQL), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Pain Therapeutics, Inc. (NASDAQ:PTIE), and Amicus Therapeutics, Inc. (NASDAQ:FOLD). This group of stocks are in the biotechnology industry and their market caps are similar to BDSI’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!